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Three influenza viruses, A/Puerto Rico/8/34–A/England/939/69 clone 7a (H3N2), A/Fiji/15899/83 (H1N1), and A/Victoria/3/75 (H3N2),
induce different levels of apoptosis in vitro at equal moi; Clone 7a N A/Victoria N A/Fiji. Previous studies have shown that several viral
proteins from clone 7a and A/Fiji, including PB2, NA, NS1, M1, and M2, induce apoptosis when expressed individually fused to the herpes
simplex virus tegument protein, VP22. However, this did not reflect viral protein–protein–RNA interactions known to occur within infected
cells. To explore the role of viral proteins in apoptosis under infection conditions, recombinant viruses with single or triple gene exchanges
were generated using A/Victoria or clone 7a as the background virus. Inserting the A/Fiji NS or PB2 gene into A/Victoria or clone 7a
significantly reduced the level of apoptosis compared to the parent virus while clone 7a PA or NP genes increased apoptosis. Inserting A/Fiji
NA or HA or clone 7a NS, M, NA, or HA genes individually into A/Victoria had no significant effect on apoptosis. Surprisingly, inserting the
M, NA, and HA genes of A/Fiji together into clone 7a reduced apoptosis, whereas inserting clone 7a M, NA, and HA together into A/Fiji
increased apoptosis. These results suggest that no single virus protein induces apoptosis and that the combination of genes required may be
strain specific, highlighting the difficulty of predicting the virulence of new strains that arise in nature. No support for the view that apoptosis
is essential for high virus yields was obtained as high virus yields were obtained with viruses that induced both high and low levels of
apoptosis.
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Influenza A virus induces apoptosis in a variety of cell
types both in vitro and in vivo (Fesq et al., 1994; Govorkova
et al., 1996; Hinshaw et al., 1994; Mori et al., 1995; Price et
al., 1997; Takizawa et al., 1993). The reason why influenza0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2005.02.019
B The nucleotide sequences of the PA and NP of clone 7a and A/Fiji have
been submitted to the EMBL nucleotide sequence database and given the
following accession numbers: clone 7a PA, AJ605763; A/Fiji PA,
AJ605762; clone 7a NP, AJ628067; A/Fiji NP, AJ628066.
T Corresponding author. Fax: +44 121 414 5925.
E-mail address: c.sweet@bham.ac.uk (C. Sweet).
1 Current address: School of Biological Sciences, University of Warwick,
Gibbet Hill Road, Coventry CV4 7AL, UK.virus induces apoptosis has been hotly debated. It was
thought that apoptosis was primarily a host defense
mechanism, limiting virus replication, and that influenza
virus overcame this by rapid multiplication before apoptosis
was induced (Kurokawa et al., 1999). However, there is now
evidence that induction of apoptosis is essential for
replication. Nuclear factor (NF)-nB dependent induction
of TRAIL and Fas/FasL, and subsequent activation of
caspase-3, all known to be involved in apoptosis induction
(Fujimoto et al., 1998; Takizawa et al., 1995, 1999; Wada et
al., 1995), are essential for virus propagation (Wurzer et al.,
2003, 2004). Efficient viral mRNA synthesis has also been
shown to correlate with apoptosis induction (Stray and Air,
2001).05) 198–211
Table 1
Recombinant viruses generated using the 12 plasmid reverse genetics
system
Background virus RNA segment(s) introduced Recombinant virus
A/Victoria rVictoria
Fiji NS rVicFNS
Fiji NA rVicFNA
Fiji NP rVicFNP
Fiji HA rVicFHA
Fiji PA rVicFPA
Fiji PB2 rVicFPB2
Fiji PA, PB2, PB1 rVicFpoly
7a NS rVic7aNS
7a M rVic7aM
7a NA rVic7aNA
7a NP rVic7aNP
7a HA rVic7aHA
7a PA rVicPA
7a PB2 rVic7aPB2
7a PB1 rVic7aPB1
7a PA, PB2, PB1 rVic7apoly
clone 7a r7a
Fiji NS r7aFNS
Fiji NA r7aFNA
Fiji NP r7aFNP
Fiji HA r7aFHA
Fiji PA r7aFPA
Fiji PB2 r7aFPB2
Fiji PB1 r7aFPB1
Fiji M, NA, HA r7aFM:NA:HA
A/Fiji rFiji
7a NS rFiji7aNS
7a M rFiji7aM
7a M, NA, HA rFiji7aM:NA:HA
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ing apoptotic responses in infected cells. The dsRNA
binding non-structural protein NS1 appears to down-regu-
late apoptosis (Morris et al., 2002; Zhirnov et al., 2002),
although when expressed from a plasmid, in the absence of
virus replication, this protein induces apoptosis (Morris et
al., 2002; Schultz-Cherry et al., 2001). Neuraminidase (NA)
activates transforming growth factor (TGF)-h, a known
inducer of apoptosis in epithelial cells (Morris et al., 1999,
2002; Schultz-Cherry and Hinshaw, 1996). It is believed
that NA removes sialic acid residues attached to carbohy-
drates on the latent (TGF)-h binding protein, which is
complexed with pro-(TGF)-h. This allows the subsequent
removal of the carbohydrate, a pre-determinant for the
proteolytic cleavage of pro-(TGF)-h and release of the
active molecule (Miyazono and Heldin, 1989). The newly
discovered PB1-f2 induces apoptosis in vitro, in a cell-
specific manner (Chen et al., 2001), by the formation of ion
channels in the mitochondrial membrane (Chanturiya et al.,
2004; Gibbs et al., 2003). PB1 and PB2 have also been
implicated in the induction of apoptosis. Different levels of
apoptosis induced in lymphocytes infected with either a
virulent or non-virulent H5N1 influenza virus strain
correlated with amino acid changes in PB1, PB2, and NA
(Katz et al., 2000; Tumpey et al., 2000). The matrix protein,
M1, interacts directly with, and may inhibit, caspase-8
(Timofeeva et al., 2001; Zhirnov et al., 1999). However,
when expressed individually from a plasmid, both M1 and
M2 induced apoptosis (Morris et al., 2002).
These conflicting results may be due to the experimental
conditions used, e.g., expression of individual viral proteins
in the absence of others or essential intermediates of viral
replication such as dsRNA. Alternatively, as some viruses
induce different levels of apoptosis when inoculated at equal
moi (Mohsin et al., 2002; Price et al., 1997), viral proteins
from different strains may differ in their ability to modulate
the apoptotic response. Clearly, the role of each viral protein
in influenza virus-induced apoptosis still needs to be
resolved.
In this study, the RNA polymerase I reverse genetics
system was employed to explore the role of each of the viral
proteins in influenza virus-induced apoptosis. Recombinant
viruses, with single or triple gene exchanges, were
generated from 3 parent strains, A/Puerto Rico/8/34–A/
England/939/69 clone 7a (H3N2), A/Fiji/15899/83 (H1N1)
(A/Fiji), and A/Victoria/3/75 (H3N2) (A/Victoria). These
three viruses induce different levels of apoptosis in vitro,
clone 7a induces greater levels of apoptosis than A/Victoria
which, in turn, induces greater levels of apoptosis than A/
Fiji (Mohsin et al., 2002). These differences were exploited
to investigate the role of each viral protein in different
genetic backgrounds. We show that the level of apoptosis
induced by each virus strain cannot be predicted by its
genetic configuration as the viral gene exchanged and the
background into which it is inserted influence the level of
apoptosis induced. In addition, there is no evidence tosupport the view that replication is related to the level of
apoptosis induced.Results
Generation of recombinant viruses
The viruses generated using the twelve plasmid reverse
genetics system are described in Table 1. The genotype of
each virus was confirmed by RT-PCR and sequence
analysis. Three recombinant viruses with single gene
exchanges could not be generated. Five attempts to generate
A/Victoria and clone 7a recombinant viruses containing the
A/Fiji M gene and six attempts to generate A/Victoria
recombinant viruses containing the A/Fiji PB1 gene were
unsuccessful. However, the same pPolFM and pPolFPB1
plasmid preparations were used to generate rFiji, indicating
that the failure was not due to the construction or
preparation of these plasmids and that introducing A/Fiji
M or PB1 into A/Victoria may result in production of non-
viable virus. This may be due to the inserted gene product
being incompatible with one or more of the background
virus gene products.
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(apoptosis)
We have previously shown that clone 7a and A/Fiji
induce apoptosis rather than necrosis in MDCK cells using
morphological analysis, DNA laddering, and TUNEL
(Brydon et al., 2003; Price et al., 1997). We have also
shown that calculating total apoptotic cell death from
percentage cytotoxicity and morphological apoptosis is
essential for comparing viruses (Mohsin et al., 2002).
Surprisingly, the level of infection induced by different
viruses was not uniform despite the use of a high moi
(4 TCID50/cell). For example, A/Fiji induced an infection
level of 95–100%, A/Victoria of 50–75%, and clone 7a of
95–100%. This was also evident with the recombinant
viruses. Since the total level of infection induced by different
viruses was reproducibly different, it was not appropriate to
compare the total number of apoptotic cells induced by
different viruses without reference to the total number of
infected cells. This is meaningful as we have never observed
in this system an apoptotic cell that was not infected.
Thus, to compare viruses, the number of apoptotic cells
is expressed as a percentage of the total number of infected
cells.
Total apoptotic cell death induced by the parent and
recombinant viruses
A/Victoria, clone 7a, and A/Fiji differ in the level of
apoptosis induced at equal moi (5 50% egg infectious doses/
cell); clone 7a N A/Victoria N A/Fiji (Mohsin et al., 2002).
During this study, cells were infected with an moi of either 2
or 4 TCID50/cell. To confirm that the differential induction
of apoptosis is still observed at equal TCID50, MDCK cells
were infected with 4 TCID50/cell of clone 7a, rVictoria, or
A/Fiji, and the level of apoptosis determined 24 h afterFig. 1. Total apoptotic cell death induced by viruses with exchanged NS genes. M
A/Fiji, rVic7aNS, rVicFNS, r7aFNS, or rFiji7aNS. Columns represent the mean peinfection. In 2 experiments, the levels of total apoptotic cell
death were 58.2% (SD 7.9) and 74.4% (SD 4.3) for clone
7a, 28.8% (SD 4.0) and 39.4% (SD 6.0) for A/Victoria, and
13.7% (SD 3.7) and 9.6% (SD 2.2) for A/Fiji. The level of
total apoptotic cell death varied between experiments, but in
each experiment the difference between the three viruses
was significant (P b 0.05). The levels of total apoptotic cell
death induced by the recombinant viruses, r7a and rFiji,
were not significantly different (P N 0.05) from that of the
parent viruses, clone 7a and A/Fiji, respectively; 57.3% (SD
1.6) for r7a compared to 56.7% (SD 5.0) for clone 7a and
7.1% (SD 0.8) for rA/Fiji compared to 7.3% (SD 2.1) for
A/Fiji.
Apoptosis induced by recombinant viruses containing A/Fiji
or clone 7a NS segments
MDCK cells were infected with 4 TCID50/cell of clone
7a, rVictoria, A/Fiji, rVicFNS, r7aFNS, rVic7aNS, or
rFiji7aNS, and the level of apoptosis determined 24 h after
infection. A typical experiment is shown in Fig. 1. rVicFNS
induced less apoptosis than rVictoria (Fig. 1) in all 6
experiments. In 5 of these, this reduction was significant
(P b 0.05). The level of apoptosis induced by rVicFNS was
similar to that observed for A/Fiji. Inserting A/Fiji NS gene
into clone 7a also significantly reduced (P b 0.01) the level
of apoptosis induced (Fig. 1) with respect to clone 7a in all 6
experiments. Again the level of apoptosis induced by
r7aFNS was not significantly different (P N 0.05) to that
of A/Fiji.
In contrast, introducing clone 7a NS into rVictoria did
not significantly affect (P N 0.05) the level of apoptosis
induced in any of 6 experiments (Fig. 1), although in 5 of
these the level induced by rVic7aNS was higher than that of
rVictoria. Due to the interesting results obtained for viruses
containing A/Fiji NS, rFiji7aNS virus was generated forDCK (NBL-2) cells were infected with 4 TCID50/cell of rVictoria, clone 7a,
rcentage of total apoptotic cell death of 3 replicate samples (FSD) 24 h pi.
S.J. Morris et al. / Virology 335 (2005) 198–211 201comparison. Inserting clone 7a NS gene into A/Fiji
increased the total apoptotic cell death induced compared
to A/Fiji (Fig. 1). In 2 out of 3 experiments, this increase
was significant (P b 0.05). However, the level of apoptosis
was significantly lower (P b 0.01) than that induced by
clone 7a.
Apoptosis induced by recombinant viruses with exchanged
NA and HA genes
MDCK cells were infected with either 4 TCID50/cell of
clone 7a, rVictoria, A/Fiji, rVicFNA, r7aFNA, or rVic7aNA,
or 2 TCID50/cell of clone 7a, rVictoria, A/Fiji, rVicFHA,
r7aFHA, or rVic7aHA, and the level of apoptosis deter-
mined 24 h after infection. Different inocula were necessary
for comparison as some viruses did not grow sufficiently
well to allow comparison at the standard inoculum of 4
TCID50/cell. Five to six experiments were performed for
each virus and 3 representative experiments are shown in
Table 2. Inserting clone 7a or A/Fiji NA gene into A/
Victoria had no significant effect (P N 0.05) on the level ofTable 2
Total apoptotic cell death, NA activity, and HI titer of recombinant viruses with
Virus Percent total apoptotic cell deatha
Experiment 1
(SD)
Experiment 2
(SD)
Experiment 3
(SD)
a.
rVictoria 28.2 (4.0) 38.0 (3.4) 50.4 (14.1)
Clone 7a 58.2 (7.9) 88.9 (1.6) 59.3 (6.5)
A/Fiji 13.7 (3.7) 19.0 (2.4) 16.2 (2.5)
rVic7aNA 20.9 (1.3) 38.3 (11.7) 48.4 (8.9)
rVicFNA 38.5 (14.4) 53.2 (18.3) 39.1 (8.5)
r7aFNA 53.1 (12.4) 86.1 (19.0) ND
b.
rVictoria 24.3 (2.4) 24.6 (3.1) 24.1 (3.7)
Clone 7a 72.6 (5.1) 45.5 (2.0) 70.7 (8.8)
A/Fiji 6.4 6.4 (2.3) 16.7 (6.1) 24.8 (4.9)
rVic7aHA 23.8 (4.0) 25.0 (3.3) 60.7 (18.2)
rVicFHA 19.5 (4.3) 14.6 (3.2)T 16.1 (5.3)
r7aFHA 43.7 (1.1)TT 37.5 (9.8) 63.4 (7.3)
c.
Clone 7a 52.8 (2.5) 74.4 (4.3) 80.7 (4.3)
A/Fiji 5.3 (1.5) 9.6 (2.2) 6.3 (5.6)
rFiji7aM:NA:HA 25.3 (2.1)TT 57.8 (7.5)TT 21.6 (4.8)T
r7aFM:NA:HA 8.0 (1.4)TT 12.1 (3.8)TT 13.0 (6.5)TT
a Total apoptotic cell death was calculated from the level of cytotoxicity (the nu
morphological apoptosis (those cells that remain on the coverslip and have charac
Standard deviations were calculated from 3 replicate wells (n = 3).
b NA activity measured using the standard WHO assay with fetuin as the substrate
h incubation period. All viruses were diluted to 80 HA units/ml for assay. The re
representative of 3 similar experiments.
c NA activity measured as above but all viruses diluted to the equivalent of 4 T
experiment but are representative of 3 similar experiments.
d HI titer expressed as the reciprocal of the highest dilution of horse serum (a-m
T Significantly different from parent virus (P b 0.05).
TT Significantly different from parent virus (P b 0.01).apoptosis induced compared to rVictoria in 6 and 5 out of 6
experiments, respectively (Table 2a). Similarly, r7aFNA did
not induce a significantly different (P N 0.05) level of
apoptosis compared to clone 7a (Table 2a).
The levels of apoptosis induced by rVic7aHA and
r7aFHA were not significantly different (P N 0.05) from
those induced by rVictoria and clone 7a, respectively, in 3
out of 5 experiments (Table 2b). Although not significant,
in most experiments, the levels of apoptosis induced by
both rVicFHA and r7aFHA were lower than that of the
respective parent virus. The level of apoptosis induced by
rVic7aHA was also not significantly different (P N 0.05)
from that induced by rVictoria in 4 out of 5 experiments
(Table 2b). However, no overall trend was observed for this
virus.
NA activity and binding affinity of recombinant viruses with
exchanged NA or HA genes
To maintain the appropriate balance between attachment/
entry and release/spread, the NA and HA evolve together;exchanged (a) NA, (b) HA, and (c) M, NA, and HA
NA activity based on NA activity based HI titerd
number of particles
[AM NANA released
over 18h] (SD)b
on 4TCID50
[AM NANA released
over 18h] (SD)c
0.21 (0.02) 0.05 (0.0) 32–64
0.74 (0.12) 1.18 (0.23) 256–512
0.22 (0.0) 1.05 (0.13) 8–16
0.73 (0.19) 0.23 (0.01) 64–128
0.21 (0.17) 0.35 (0.09) 32
0.51 (0.04) 0.09 (0.0) 128–256
0.21 (0.02) 32–64
0.74 (0.12) 512
0.22 (0.0) 4–8
0.31 (0.01) 128
0.16 (0.01) 8
0.75 (0.13) 4–8
mber of cells that have entered late apoptosis and lysed) and the level of
teristic nuclear fragmentation as determined by propidium iodide staining).
and is expressed as AM N-acetyl neuraminic acid (NANA) released over 18-
sults show the means (FSD) of 2 replicates in a single experiment but are
CID50/cell. The results show the means (FSD) of 2 replicates in a single
acroglobulin) that still caused complete inhibition of hemagglutination.
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highly active NA (Mitnaul et al., 2000). To ensure that the
observed effects were due to the exchanged gene and not
due to mutations in the HA arising from changing the NA,
or from mutations in the exchanged NA due to the
background HA and vice versa, the NA activities and
binding affinity of the HA were determined. The NA
activities of rVictoria, clone 7a, and A/Fiji, based on equal
number of particles, showed that clone 7a N A/Fiji =
rVictoria (Table 2a). The NA activity of the recombinant
viruses, rVic7aNA and rVicFNA, based on equal number
of particles, mirrored that of the parent from which the NA
gene was derived (Table 2a). However, the NA activity of
r7aFNA, based on equal number of particles, was
significantly higher than that of A/Fiji (P b 0.05), although
it was significantly lower (P b 0.05) than that of clone 7a.
This difference in NA activity is not due to sequence
changes in the NA gene per se as full-length sequence
analysis of segment 6 from r7aFNA revealed 100%
identity to segment 6 of A/Fiji.
The NA activities of rVic7aNA and rVicFNA at equal
infectivity (4 TCID50/cell, used in the apoptosis assays)
were significantly higher (P b 0.05) than that of rVictoria
(Table 2a) but significantly lower than that of clone 7a and
A/Fiji. The NA activity of r7aFNA at equal infectivity was
also significantly lower compared to clone 7a and A/Fiji.
The NA activities of clone 7a and A/Fiji, at equal infectivity,
although significantly higher (P N 0.05) than that of the
recombinant viruses rVictoria, rVic7aNA, rVicFNA, and
r7aFNA, were not significantly different (P N 0.05) from
each other (Table 2a).
The differences in NA activities for the same virus
calculated from particle numbers and TCID50 probably
reflect the variation (F2-fold) in HA estimations for the
viruses. Nevertheless, they do show that the NA activities of
the recombinant viruses were similar to those of the parent
from which the NA was derived.
The NA activities of the recombinant viruses, rVic7aHA,
rVicFHA, and r7aFHA, based on equal number of
particles, were similar to the parent from which the NA
gene was derived (Table 2b).
The binding affinity of the recombinant virus’ HAs was
determined, as judged by binding to erythrocytes in the
presence of a-2 macroglobulin, the a-2,6 receptor inhibitor
in horse serum (Mohsin et al., 2002). The binding affinities
of rVic7aNA, rVicFNA, r7aFHA, rVicFHA, rVic7aHA, and
r7aFHAwere similar to the parent virus from which the HA
was derived (Table 2b).
Apoptosis induced by recombinant viruses with exchanged
M gene
As previously described, neither an A/Victoria nor a
clone 7a recombinant virus containing A/Fiji M gene
could be generated. When used to infect MDCK cells at a
moi of 4 TCID50/cell, both rVic7aM and rFiji7aM induceda level of apoptosis that was not significantly different
(P N 0.05) from rVictoria [16.4 (SD 0.9) for rVic7aM
compared to 24.0 (SD 3.6) for rVictoria] or A/Fiji,
respectively [5.3 (SD 1.6) for rFiji7aM compared to 2.3
(SD 0.5) for A/Fiji].
Apoptosis inducing ability of recombinant viruses with
exchanged HA, NA, and M genes
The above results suggested that generating a recombi-
nant clone 7a virus containing A/Fiji M, NA, and HA
genes (Table 1) or a recombinant A/Fiji virus containing
clone 7a M, NA, and HA genes (Table 1) should still
behave like clone 7a and A/Fiji, respectively. However,
rFiji7aM/NA/HA induced significantly more apoptosis than
A/Fiji, whereas r7aFM/NA/HA induced significantly less
apoptosis than clone 7a in all 3 experiments (Table 2c).
These results contradict those obtained for recombinant
viruses with single gene exchanges, possibly indicating that
apoptosis induction may depend on viral protein–protein
interactions.
Apoptosis induced by recombinant viruses with exchanged
NP genes
MDCK cells were infected with 2 TCID50/cell of clone
7a, rVictoria, A/Fiji, rVicFNP, r7aFNP, or rVic7aNP, and
the level of apoptosis determined 24 h later. Three to five
experiments were performed for each virus and a typical
experiment is shown in Fig. 2. rVicFNP induced a
significantly higher (P b 0.05) level of apoptosis than
rVictoria in all 5 experiments (Fig. 2). In contrast, r7aFNP
induced a significantly (P b 0.05) lower level of apoptosis
than clone 7a in 3 out of 4 experiments (Fig. 2). The level
of apoptosis induced by rVic7aNP was also significantly
greater (P b 0.05) than that induced by rVictoria in 3 out
of 5 experiments. While not always significant, in all
5 experiments, the level of total apoptotic cell death
induced by rVic7aNP was higher than that induced by
rVictoria.
Apoptosis induced by recombinant viruses with exchanged
PA, PB2, and PB1 genes
MDCK cells were infected with 4 TCID50/cell of clone
7a, rVictoria, A/Fiji, rVicFPB2, r7aFPB2 rVic7aPB2,
rVicFPA, r7aFPA, rVic7aPA, or rVic7aPB1. Inserting A/
Fiji PA gene into A/Victoria had no significant effect (P N
0.05) on the level of apoptosis induced 24 h pi compared to
rVictoria (Fig. 3), although the level of apoptosis induced
was higher than that induced by rVictoria in 4 out of 5 of
these experiments. In contrast, r7aFPA reproducibly induced
less apoptosis than clone 7a, but again this reduction was
only significant in 1 out of 3 experiments. rVic7aPA induced
a significantly higher level (P b 0.01) of apoptosis than
rVictoria in 4 out of 5 experiments (Fig. 3).
Fig. 2. Total apoptotic cell death induced and virus yields generated by viruses with exchanged NP genes. MDCK (NBL-2) cells were infected with 2 TCID50/
cell of rVictoria, clone 7a, A/Fiji, rVic7aNP, rVicFNP, or r7aFNP. Columns represent the mean percentage of total apoptotic cell death of 3 replicate samples
(FSD) 24 h pi; data points represent virus yields in log10 TCID50/ml.
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in 4 out of 5 experiments; in 3 of these, this reduction was
significant (P b 0.05). Similarly, 7aFPB2 induced signifi-
cantly less (P b 0.05) apoptosis than clone 7a in 4 out of 5
experiments. However, the level of apoptosis induced by
rVic7aPB2 was not significantly different from that induced
by rVictoria.
As previously described, rVicFPB1 could not be gen-
erated. Interestingly, r7aFPB1 also grew poorly and only
reached sufficient titers to be inoculated at an moi of 0.1
TCID50/cell. A comparison with clone 7a at this moi
showed that r7aFPB1 produced less apoptosis than clone
7a in 3 out of 3 experiments (typically 20.8% (SD 3.5) for
r7aFPB1 compared to 68.4% (SD 7.9) for clone 7a). In 2 of
these experiments, the reduction in apoptosis was significant
(P b 0.05). The level of apoptosis induced by 4 TCID50/cellFig. 3. Total apoptotic cell death induced and virus yields generated by viruses wit
cell rVictoria, clone 7a, A/Fiji, rVic7aPA, rVicFPA, or r7aFPA. Columns represe
(FSD) 24 h pi; data points represent virus yields in log10 TCID50/ml.rVic7aPB1 was not significantly different from rVictoria
[51.94% (SD 10.7) for rVic7aPB1 compared to 46.9% (SD
5.3) for rVictoria] in any of the 3 experiments.
Apoptosis induced by A/Victoria recombinant viruses
containing either clone 7a or A/Fiji PB2, PB1, and PA genes
To investigate the polymerase proteins further, recombi-
nant viruses were generated which contained A/Fiji PB1,
PB2, and PA (rVicFpoly) or clone 7a PB1, PB2, and PA
gene (rVic7apoly) segments in an A/Victoria background
(Table 1). rVicFpoly induced a level of apoptosis not
significantly different to that induced by rVictoria (Fig. 5) in
any of 3 experiments. In contrast, rVic7apoly induced more
apoptosis than rVictoria in 3 experiments (Fig. 5) and, in 2
of these, this increase was significant (P b 0.05).h exchanged PA genes. MDCK (NBL-2) cells were infected with 4 TCID50/
nt the mean percentage of total apoptotic cell death of 3 replicate samples
Fig. 4. Total apoptotic cell death induced and virus yields generated by viruses with exchanged PB2 genes. MDCK (NBL-2) cells were infected with 4 TCID50/
cell of rVictoria, clone 7a, A/Fiji, rVic7aPB2, rVicFPB2, or r7aFPB2. Columns represent the mean percentage of total apoptotic cell death of 3 replicate
samples (FSD) 24 h pi; data points represent virus yields in log10 TCID50/ml.
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exchanged NP or polymerase proteins
As the polymerase proteins and NP are all involved in
influenza virus replication, exchanging these genes might
affect the rate and/or efficiency of replication. Therefore,
virus yields were determined 24 h after infection. A/Fiji
consistently induced a significantly lower level of apoptosis
than clone 7a and rVictoria but produced similarly high viral
yields (Figs. 2–5). Generally, recombinant viruses replicated
less well than their parental viruses, but this appears to be
independent of the level of apoptosis induced (Figs. 2–5).
For example, rVic7aPA, rVicFPA, and r7aFPA virus yields
were 10- to 50-fold lower than their respective parental
viruses but whereas r7aFPA produced lower levels of
apoptosis than clone 7a, both rVic7aPA and rVicFPA
induced higher levels of apoptosis than rVictoria (Fig. 3).Fig. 5. Total apoptotic cell death induced and virus yields generated by viruses wit
with 4TCID50/cell of rVictoria, clone 7a, A/Fiji, rVic7aPoly, or rVicFpoly. Colum
samples (FSD) 24 h pi; data points represent virus yields in log10 TCID50/ml.In contrast, the low yields of rVic7aPB2 and rVicFPB2
correlated with an increased level of apoptosis for the former
and a decrease for the latter (Fig. 4). Similarly, the increased
levels of apoptosis induced by rVic7aNP and rVicFNP were
not associated with a change in virus yields (Fig. 2).Discussion
Previous investigations of the role of individual viral
proteins in influenza virus-induced apoptosis have relied on
their expression in a range of mammalian cells or use of
mutant, gene-knockout viruses. However, these approaches
have problems in that expression of individual viral proteins
ignores viral protein–protein–RNA interactions known to
occur during infection. Here we have examined the role of
the viral proteins during infection by exploiting the twelveh exchanged PA, PB2, and PB1 genes. MDCK (NBL-2) cells were infected
ns represent the mean percentage of total apoptotic cell death of 3 replicate
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viruses with single or triple gene exchanges.
The NS gene from A/Fiji caused a significant decrease in
the level of total apoptotic cell death when inserted into A/
Victoria or clone 7a (Fig. 1). This is the first time that any
influenza virus gene has been shown to have a role in the
differences observed in the apoptotic response between
viruses. Segment 8 encodes 2 products, NS1 and nuclear
export protein (NEP, NS2), but it is more likely that NS1
mediates the effect as apoptosis increased in cells infected
with a NS1 deletion mutant (Zhirnov et al., 2002) and NS1
expressed from a plasmid reduced dsRNA-induced apopto-
sis (Morris et al., 2002). This is also supported by the
observation that at the amino acid level A/Fiji NS1 is only
91% and 86% identical to that from A/Victoria and clone 7a,
respectively, whereas A/Fiji NEP is 97% and 99% identical
to that from A/Victoria and clone 7a, respectively (Fig. 6).
However, all the amino acids known to be directly involved
in the multiple functions of NS1 and NEP are conserved for
all 3 viruses. NS1 may act directly by binding to PKR, an
apoptosis mediator (Tan and Katze, 1998), sequestering
dsRNA (Hatada and Fukuda, 1992) or inhibiting the c-Jun
N-terminal kinase (JNK)/AP1 stress activated transcription
pathway (Ludwig et al., 2002) known to be involved in the
induction of apoptosis by equine influenza virus (Lin et al.,
2001). Alternatively, NS1 may act indirectly by inhibiting
late viral gene expression (Enami and Enami, 2000; Falcon
et al., 2004) or by controlling the switch from transcription
to replication (Falcon et al., 2004), which could affect both
mRNA and dsRNA levels. However, a role for NEP cannot
be excluded as it exports progeny ribonucleoprotein com-
plexes out of the nucleus via its interaction with matrix
protein 1 (M1) and nucleoporins (O’Neill et al., 1998). It
also down-regulates the synthesis of vRNA, cRNA, and
mRNA in a dose-dependent manner (Bullido et al., 2001).
This could cause a reduction in either the dsRNA concen-
tration within infected cells or the level of a viral-apoptosis-
inducing protein.
We and others have reported that NA is involved in the
induction of apoptosis (Morris et al., 1999; Schultz-Cherry
and Hinshaw, 1996). Here, however, inserting the NA genes
of clone 7a and A/Fiji into A/Victoria and the NA gene of
A/Fiji into clone 7a had no affect on apoptosis, even though
the three parent viruses have different NA activities based
on equal number of particles (Table 2). At equal TCID50, a
virus sample contains an equal number of infectious
particles but an unknown number of non-infectious par-
ticles, all with NA activity. NA induces apoptosis at the cell
surface before virus enters the cell (Morris et al., 1999) so
both infectious and non-infectious particles can contribute to
the process. It can thus be argued that measuring the NA
activity of the inoculum measures the NA activity relevant
to the induction of apoptosis. Therefore, the NA activity of
the inocula was determined. Even though NA activities of
rVic7aNA and rVicFNA inocula were higher than that
of rVictoria, the level of apoptosis induced by all threeviruses was not significantly different. Similarly, the NA
activity of the r7aFNA inoculum was considerably lower
than that of clone 7a, yet the level of apoptosis induced was
similar. In addition, clone 7a and A/Fiji had comparable NA
activities at the inocula used, but the levels of apoptosis
were significantly different. These results suggest that the
role of NA in influenza virus-induced apoptosis is limited
and not responsible for the differential induction of
apoptosis observed between A/Victoria, clone 7a, and
A/Fiji.
Neither HA nor M caused a significant difference in the
induction of apoptosis. This was despite the fact that over-
expression of HA and M from plasmids has been reported to
induce apoptosis through endoplasmic reticulum stress
(Flory et al., 2000) and that M1 may be a caspase inhibitor
(Timofeeva et al., 2001).
To maintain the appropriate balance between attachment/
entry and release/spread, the NA and HA evolve together;
viruses with a strong affinity for their receptors require a
highly active NA (Mitnaul et al., 2000). However, in this
study, no differences in NA activity or binding affinity,
based on equal number of particles, were observed for the
recombinant viruses with exchanged NA or HA genes with
the exception of r7aFNA (Table 2a). The NA activity of
r7aFNA was higher than that of A/Fiji but still lower than
that of clone 7a. However, sequence analysis of segment 6
from r7aFNA did not reveal any changes compared to that
from A/Fiji. This difference in NA activity must therefore
relate to number of NA per virion. Interestingly, clone 7a is
a spherical virus (C. Sweet, unpublished observations),
whereas A/Fiji is filamentous (W. Barclay, unpublished
observations). A difference in shape may result in differ-
ences in number of NA per virion accounting for the
difference in NA activity observed.
The single gene exchange recombinant viruses suggest
that NS is involved in influenza virus-induced apoptosis
whereas NA, HA, and M are not. However, inserting the M,
NA, and HA gene of clone 7a into A/Fiji and vice versa
confounded this latter conclusion. rFiji7aM/NA/HA, which
retains the A/Fiji NS gene, induced significantly more
apoptosis than A/Fiji (Table 2c). Similarly, r7aFM/NA/HA
induced significantly less apoptosis than clone 7a (Table
2c). Together, M, NA, and HA have an effect on apoptosis
that they did not exert individually. Inserting clone 7a M,
NA, and HA into A/Fiji induced a less dramatic effect
compared to inserting A/Fiji M, NA, and HA into clone 7a,
probably due to the inhibitory effect exerted by A/Fiji NS in
rFiji7aM/NA/HA. These differences may also be due to a
difference in virion shape. However, a change in virion
shape from spherical to filamentous or vice versa cannot be
solely responsible for these results as rVic7aM and
rFiji7aM, both of which would be predicted to be spherical,
did not induce a significant difference in apoptosis
compared to rVictoria and A/Fiji, respectively, both of
which are filamentous (Elleman and Barclay, 2004; W.
Barclay, unpublished observations). However, it has been
Fig. 6. Amino acid alignments of (a) NS1 and (b) NS2 for clone 7a, A/Fiji, and A/Victoria. Amino acid differences between A/Fiji and A/Vic are indicated with
an asterisk (*) whereas amino acid differences between A/Fiji and clone 7a are indicated with a cross (y).
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can result in irregularly shaped virions (Jin et al., 1997;
Mitnaul et al., 1996). In addition, mutational analysis of the
cytoplasmic tail and transmembrane domain of NA has
revealed that NA can influence virus shape, size, and titer(Barman et al., 2004), thus it cannot be ruled out that
changing all three (NA, HA, and M) genes would have a
more profound effect. The level of apoptosis induction
could be related to differences in viral infection of
morphologically different viruses as differences in infection
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at equal TCID50/cell. However, this seems unlikely as total
apoptotic cell death was calculated as a percentage of the
total number of infected cells. Alternatively, the results may
be due to differences in transcription of M, NA, and HA as
the presence of a C or U at position 4 of the 3’ terminus has
been shown to be responsible for differences in transcription
(Lee and Seong, 1998). However, the clone 7a and A/Fiji M,
NA, and HA gene segments generated possess identical 3’
termini (with a U at position 4) and thus should be
expressed at comparable levels.
Inserting A/Fiji NP into A/Victoria induced a significant
increase in the induction of apoptosis compared to rVictoria
(Fig. 2). In contrast, inserting A/Fiji NP into clone 7a
resulted in a significant decrease in the level of apoptosis
compared to clone 7a (Fig. 2). These results suggest that the
effect of A/Fiji NP is dependent on its interaction with
another viral protein and the degree of interaction is
different between the A/Victoria and clone 7a viruses.
The primary role of NP is to encapsidate the virus genome
but it is multifunctional. It interacts with many cellular and
viral proteins and is thus a key adaptor molecule between
viral and host processes (Portela and Digard, 2002). NP
interacts directly with PB1 and PB2 but not PA (Biswas et
al., 1998) and in addition binds M1 (Ye et al., 1999).
Interestingly, at the amino acid level, A/Fiji NP is 97.8%
and 94.8% identical to that from A/Victoria and clone 7a,
respectively, whereas clone 7a NP shares 97% identity with
A/Victoria NP. There are two (N34D and R77K) and four
(K47R, S50N, N34G, and R77K) amino acid changes
located in the minimal RNA binding region (Portela and
Digard, 2002) of A/Fiji NP compared to A/Victoria and
clone 7a, respectively. These changes also locate within the
PB2 binding region. A/Fiji contains further a 6 and 16
amino acid differences compared to A/Victoria and clone
7a, respectively, in this region. In addition, changes were
observed in the C-terminal region responsible for the
suppression of PB2-NP binding, and in the oligomerization
regions. It is unknown at present how these sequence
differences relate to the differential induction of apoptosis
observed.
The role of the polymerase proteins, per se, in the
induction of apoptosis has not previously been studied.
Inserting A/Fiji PB2 into A/Victoria or clone 7a resulted in a
decrease in apoptosis compared to the respective parent
viruses (Fig. 4), which again could be due to a change in the
degree of compatibility with parent NP. However, the level
of apoptosis induced by rVicFpoly, containing A/FijiPB2
but not NP, did not induce a significantly different level
of apoptosis compared to rVictoria (Fig. 5). In contrast,
rVic7apoly induced a significant increase in apoptosis
induction compared to rVictoria (Fig. 5), even though no
effect was observed when clone 7a PB2 alone was inserted
into A/Victoria (Fig. 4). PB2 interacts with RNA, NP, and
PB1. Mutations in PB2, along with PB1 and NA, have been
shown to correlate with the induction of apoptosis inlymphocytes by H5N1 influenza viruses (Katz et al.,
2000; Tumpey et al., 2000), although whether this was
due to viral replication in lymphocytes or the indirect action
of cytokine induction was not evident.
The PA gene of clone 7a originates from A/PR/8/34, a
H1N1 virus like A/Fiji. However, sequence analysis reveals
that the A/Fiji PA gene shares more identity with A/Victoria
than clone 7a, which is reflected in the effect of exchanging
this gene. Inserting clone 7a PA gene into A/Victoria
resulted in a significant increase in apoptosis (Fig. 3). In
contrast, inserting A/Fiji PA gene into clone 7a caused a
reduction in the level of apoptosis induced. Therefore, the
effect of A/Fiji PA is, like A/Fiji NP, dependent upon the
genetic background into which it is inserted, indicating that
PA interacts via another viral or cellular protein. Further
analysis of these viruses showed that exchanging the PA
gene may affect the rate of progression of apoptosis, as more
cells were morphologically apoptotic at 12 h for both
rVic7aPA and rVicFPA compared to rVictoria (data not
shown). PA has been shown to induce generalized proteol-
ysis leading to a decrease in the steady state of co-expressed
proteins (Sanz-Ezquerro et al., 1996). This action could
potentiate the apoptotic response, which is propagated via a
proteolytic cleavage cascade. The dependence on genetic
background would then suggest that this action is modulated
by the virus.
Inserting clone 7a PB1 into A/Victoria had no effect on
the level of apoptosis induced compared to rVictoria
whereas inserting A/Fiji PB1 into clone 7a significantly
lowered the level of apoptosis. PB1 is the main catalytic
component of the polymerase complex, possessing both
transcriptase and replicase activity. Therefore, exchanging
the PB1 gene may have a profound effect on these
processes. However, segment 2 encoding PB1 also encodes
for another protein, PB1-f2. It is unknown which of these
proteins is affecting apoptosis. PB1-f2 induces apoptosis in
vitro, in a cell-specific manner (Chen et al., 2001), by the
formation of ion channels in the mitochondrial membrane
(Chanturiya et al., 2004). A/Fiji segment 2 encodes a
truncated PB1-f1 of 57 amino acids compared to the 88
amino acid protein encoded by clone 7a. A/Fiji is not unique
in encoding a truncated PB1-f2 as recent isolates from
Taiwan have also been shown to encode a 57 amino acid
PB1-f2 (Chen et al., 2004). The mitochondrial localization
signal is located within the C-terminal end of PB1-f2,
therefore translocation of A/Fiji PB1-f2 to the mitochondria
will not occur. This may account for the reduction in
apoptosis observed when A/Fiji PB1 was inserted into clone
7a. However, Chen and colleagues reported that the
apoptosis inducing ability of PB1-f2 was restricted to non-
permissive cells (Chen et al., 2001).
Although caspase 3 has been shown to be essential for
virus replication in MDCK cells (Wurzer et al., 2003), the
results obtained during this study for the parent viruses,
clone 7a, rVictoria, and A/Fiji, and their recombinants
indicated no relationship between apoptosis and virus yields
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and colleagues recently reported that caspase inhibitors did
not affect virus yields generated in human bronchiolar cells
(Brydon et al., 2003). In addition, Mersich et al. (2004) have
recently shown no relationship exists between yields and
apoptosis induced by circulating influenza viruses in
Argentina and some influenza viruses that induced low
levels of apoptosis replicated to high titers in a porcine cell
line (Seo et al., 2001).
It is difficult to attribute the induction of apoptosis to a
single viral protein from these results. A/Fiji NS1 and/or
NEP down-regulates apoptosis more efficiently than that
from clone 7a or A/Victoria. However, by changing the M,
NA, and HA genes, the effect of NS1 on apoptosis can be
reduced. The level of apoptosis induced appears to depend
on the balance between the pro- and anti-apoptotic functions
of several viral proteins. These results indicate that it is hard
to predict the properties of newly emerging influenza virus
strains based on those of the parents. This also applies to
other aspects of virulence, which is multigenic, and would
make it difficult to judge the potential virulence of new
isolates such as the 1997 and 2003/2004 H5N1 Asian
isolates (Guan et al., 2004). Some of these isolates were
much more virulent than others and the genetic basis for this
is unclear. Data obtained during this study indicate that both
the background virus in which the gene being is inserted as
well as the gene exchanged must be considered in these
situations. In this respect, it is interesting that the insertion
of the 1918 virus HA into several influenza backgrounds
increased their virulence, but this was dependent on the
genetic background of the virus; the enhanced virulence of
the viruses was reduced if the 1918 NA was inserted
together with the HA (Kobasa et al., 2004). Further studies
of other aspects of pathogenicity using the approaches
described here are necessary to increase our understanding
of the epidemic potential of newly emerged viruses.Materials and methods
Biological materials
MDCK (NBL-2) and 293T cells were maintained in
growth medium [Dulbecco’s modified Eagle medium
(DMEM) with pyridoxine supplemented with 1 essential
amino acids, 10% fetal calf serum, 4 mM l-glutamine, 100
IU/ml penicillin, and 100 g/ml streptomycin (Invitrogen)].
The virus strains A/Fiji/15899/83 (H1N1) (A/Fiji) and clone
7a (H3N2) of the A/Puerto Rico/8/34 (H1N1)  A/England/
939/69 (H3N2) reassortant system and their growth have
been described previously (Price et al., 1997). All recombi-
nant viruses were passaged in MDCK NBL-2 cells in
serum-free medium containing 1 g/ml TPCK-treated trypsin.
All virus titers were determined by titrating in MDCK
(NBL-2) cells in 96-well plates. After 48 h, the supernatants
were assayed for hemagglutination to determine which wellmonolayers were infected and viral titers expressed as
log10TCID50/ml, calculated using the method of moving
averages (Thompson, 1947). Plasmids containing cDNA
copies of the vRNA segments from A/Victoria/3/75 (A/
Victoria) cloned into the transcription plasmid pPolIRT
(Jackson et al., 2002), and the vector pPolIRTBsmBI, were
kindly provided by Dr. Thomas Zuercher (GlaxoSmithK-
line, Stevenage, UK). The transcription plasmid pPolISa-
pIRib and the expression plasmids, pGT-h-PB1, pGT-h-NP,
pGT-h-PB2, and pGT-h-PA, encoding A/NWS/33 PB1 and
NP and A/PR/8/34 PB2 and PA, respectively (Fodor et al.,
1999), were kindly provided by Prof. George Brownlee
(Oxford University, Oxford, UK).
Plasmid construction
The pPolI-derived transcription plasmids, pPolFNS,
pPolFM, pPolFNA, pPolFNP, pPolFHA, pPolFPA,
pPolFPB1, pPolFPB2 containing cDNA copies of the 8
viral RNA segments from A/Fiji and pPol7aNS, pPol7aM,
pPol7aNA, pPol7aNP, pPol7aHA, pPol7aPA, pPol7aPB1,
pPol7aPB2 containing cDNA copies of the 8 viral RNA
segments from clone 7a were generated as follows. RNA
was extracted from virus stocks and cDNA generated as
described previously (Morris et al., 2002). The cDNAs were
then amplified using the EXPAND PCR system (Roche).
Primers, specific for each segment, which inserted either a
SapI or BsmBI restriction site at the termini of the 5V and 3V
untranslated regions were used (sequences available on
request). All primers were designed to contain a U at
position 4 of the 3V terminus. The PCR products were then
cloned into the blunt TOPO cloning vector, pCR4 (Invi-
trogen). The inserted segment was fully sequenced, to check
for PCR-generated mutations, using the version 3.0 Big Dye
Terminator ready reaction cycle sequencing kit (Applied
Biosystems). Inserts of correct sequence (100% identity to
the virus segment at the amino acid level) were subcloned
into either pPolISapIRib or pPolIRTBsmBI. The inserted
DNAwas sequenced over the cloning junction, as described
above, to confirm the orientation of the cloned DNA. All
sequence analysis was carried out using the influenza virus
sequence database (ISD; www.Flu.lanl.gov; Macken et al.,
2001).
Virus rescue
To rescue infectious virus, 293T cells were seeded at a
density of 1  105 cells/well in a 12-well plate. Cells were
transfected with 8 transcription plasmids (generally seven
plasmids derived from one virus and 1 plasmid derived from
another virus) (0.5 Ag each plasmid) and 4 expression
plasmids (0.5 Ag pGT-h-PB1, pGT-h-PB2, and pGT-h-PA
and 1 Ag of pGT-h-NP) prepared using the Plasmid Miniprep
kit (Qiagen). Transfections were performed using Fugene6
(Roche) at a ratio of 1:3 in growth medium with serum
reduced to 3%. After 24 h, the transfected 293Tcells were co-
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(Elleman and Barclay, 2004). Cells were examined for
cytopathic effect (cpe) over 4–5 days; supernatants were
harvested after complete cpe was observed. Cell debris was
pelleted by centrifugation at 4000 rpm for 10 min at 4 8C. The
presence of virus in the supernatant was confirmed by
hemagglutination assay. The genotype of each recombinant
virus was confirmed by sequencing. Viral RNAwas extracted
as previously described (Morris et al., 2002) and the
exchanged RNA segment and a background RNA segment,
chosen at random, were amplified by RT-PCR and sequenced
as described above.
Determination of the percentage of apoptotic and infected
cells
5  104 MDCK (NBL-2) cells were infected at an moi of
4 or 2TCID50/cell, depending on the maximum titer
achieved by each virus, as described by Price et al.
(1997). Cytotoxicity assays were performed using the
Cytotox96 assay (Promega). Morphological apoptosis was
determined by nuclear staining with propidium iodide (Price
et al., 1997). Infected cells were identified using monoclonal
antibody to the nucleoprotein of the X-31 (H3N2) influenza
virus strain and anti-mouse-FITC conjugate as previously
(Price et al., 1997). Total apoptotic cell death, determined
from percentage cytotoxicity (which measures the percent-
age of apoptotic cells which have entered late apoptosis,
detached from the monolayer, and lysed due to the absence
of phagocytes) and morphological apoptosis (which meas-
ures those cells remaining attached to the coverslip at 24 h
pi), was calculated as described by Mohsin et al. (2002).
Cytotoxicity resulting from necrosis is taken into account in
the calculation by subtracting the level of cytotoxicity
generated in mock-infected cells.
Yields
Medium from infected wells was harvested prior to
staining for apoptosis and infection. Viral yields were
determined by titrating in MDCK (NBL-2) cells as
described above. Virus yields were calculated based on
the total number of infected cells.
NA activity
NA activity of the viruses was determined based on equal
numbers of particles and equal infectivity to give a value for
absolute NA activity per virion or the relative NA activity of
the inoculum (4 or 2 TCID50/cell) used in the apoptosis
studies, respectively. The modified WHO assay using fetuin
as a substrate was performed as described previously
(Morris et al., 1999). NA activities are expressed as Amol
of N-acetyl neuraminic acid (NANA) released over the 18-h
incubation period and were calculated from a standard
curve.Hemagglutination-inhibition (HI) assays
These were performed as described by Sweet et al.
(1974) using 4HA of each virus, 1% human erythrocytes,
and horse serum which contains a-macroglobulin rich in
a2-6 galactose linkages (Ryan-Poirier and Kawaoka,
1993). The HI titers are expressed as the reciprocal of
the highest dilution that still caused complete inhibition of
hemagglutination.
Statistical analysis
Data were collated and analyzed for statistical signifi-
cance by the Student’s t test.Acknowledgments
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